PQ 678
678. Deputy Clare Daly asked the Taoiseach and Minister for Defence if the broad range of studies demonstrating the neurotoxic effects of mefloquine, Lariam, (details supplied) have been reviewed and taken into account by the chief medical officer in coming to the conclusion that the benefits of Lariam as a first line anti-malarial for the Defence Forces outweigh the costs. [39772/16]
Introduced
13 December 2016
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
13 December 2016
Summary
678. Deputy Clare Daly asked the Taoiseach and Minister for Defence if the broad range of studies demonstrating the neurotoxic effects of mefloquine, Lariam, (details supplied) have been reviewed and taken into account by the chief medical officer in coming to the conclusion that the benefits of Lariam as a first line anti-malarial for the Defence Forces outweigh the costs. [39772/16]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Defence Forces Medicinal Products
Defence Forces Medicinal Products
xml · EN · 13 December 2016
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2016-12-13/678/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2016-12-13/pq_678